Sheppard Mullin advised Ladenburg Thalmann & Co on the deal. Jaguar Health, a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
